How to Get Jatenzo in Florida

What Is Jatenzo and Why Does It Require a Specific Prescribing Process?

Jatenzo is the first FDA-approved oral testosterone replacement therapy (TRT) for adult men with clinically diagnosed hypogonadism, and its oral route creates prescribing considerations that differ from injectable or topical testosterone. It contains testosterone undecanoate absorbed via the intestinal lymphatic system, which bypasses first-pass hepatic metabolism and produces testosterone levels without the liver toxicity associated with older oral androgens such as methyltestosterone [1].

The FDA approved Jatenzo in March 2019 based on the key MAGE trial conducted by Swerdloff et al. (published in the Journal of Clinical Endocrinology and Metabolism, 2020). In that study, 87% of 166 men with hypogonadism achieved average testosterone concentrations within the normal range (300 to 1 to 000 ng/dL) over a 120-day treatment period [2]. Mean total testosterone rose from a baseline of 226 ng/dL to 462 ng/dL at steady state [2].

The drug carries an FDA boxed warning for blood pressure elevation. In the MAGE trial, 21% of participants required antihypertensive initiation or dose escalation during treatment [2]. Florida prescribers must document baseline blood pressure and schedule a follow-up measurement at approximately 6 weeks. This requirement shapes both telehealth workflows and the prior authorization packet for commercial insurers [1].

Because testosterone is a Schedule III controlled substance under the Controlled Substances Act, every Florida prescriber, whether in-office or telehealth, must be registered with the DEA and must verify a confirmed diagnosis of hypogonadism before issuing a prescription [3]. Florida law does not allow prescribing testosterone for "optimization" without a documented clinical diagnosis.

Required Laboratory Work Before a Florida Prescriber Can Write the Prescription

A minimum laboratory panel is required by both FDA labeling and Florida prescriber guidelines before Jatenzo can be initiated. Getting these labs drawn in advance shortens your first appointment considerably.

The core panel includes a morning (before 10 a.m.) total testosterone level drawn on two separate days at least one week apart [4]. Single low readings are insufficient for diagnosis under the 2018 Endocrine Society Clinical Practice Guideline, which states: "We recommend confirming the diagnosis by repeating the measurement of serum testosterone with a reliable assay" [4]. Free testosterone and sex hormone-binding globulin (SHBG) add diagnostic precision when total testosterone sits near the 264 to 400 ng/dL borderline range.

Additional required labs include luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to classify hypogonadism as primary (testicular failure) or secondary (hypothalamic-pituitary axis dysfunction). A complete metabolic panel (CMP) and complete blood count (CBC) assess hepatic function and hematocrit. Men aged 40 and older need a prostate-specific antigen (PSA) and digital rectal exam documentation before starting any TRT per American Urological Association guidance [5]. A fasting lipid panel and hemoglobin A1c are recommended given the metabolic context common to hypogonadal men [6].

Florida telehealth platforms typically partner with LabCorp or Quest Diagnostics to issue lab requisitions electronically, allowing patients to walk into any Florida draw site without a paper order. Results return within 24 to 72 hours. Once confirmed low testosterone with two morning draws, the prescribing encounter can proceed [7].

The HealthRX Clinical Team uses a standardized four-gate intake framework for Jatenzo candidates: (1) symptom qualification using the Androgen Deficiency in Aging Males (ADAM) questionnaire score of 3 or higher, (2) dual confirmatory testosterone below 300 ng/dL, (3) cardiovascular and hematologic safety screen, and (4) documented patient education on blood pressure monitoring and the boxed warning. All four gates must be satisfied before a prescription is issued.

Florida Telehealth Prescribing: How It Works Legally and Practically

Florida law permits telehealth prescribing of controlled substances under specific conditions, and testosterone qualifies. Florida Statute 456.47, substantially amended by SB 1864 in 2021, allows a Florida-licensed prescriber to conduct a patient evaluation and issue a Schedule III controlled substance prescription via synchronous audio-video telehealth, provided the prescriber holds a valid DEA registration and reviews current laboratory results during the visit [8].

The visit itself is a synchronous video call, not an asynchronous questionnaire. Asynchronous prescribing of controlled substances is not permitted under current Florida rules. Most telehealth platforms schedule these appointments within 2 to 5 business days of lab result receipt.

After the video visit, the prescriber transmits the prescription electronically to a pharmacy of the patient's choice. Florida accepts electronic prescribing for Schedule III substances under Florida Statute 893.105 [9]. Paper prescriptions are still accepted at retail pharmacies but add 1 to 2 days to fulfillment.

Telehealth prescribers operating in Florida must also be licensed in Florida specifically. A prescriber licensed only in another state cannot legally treat Florida patients for controlled substances, even via video. Patients should confirm Florida licensure before booking any telehealth visit [8].

Finding a Florida Doctor, NP, or PA Who Prescribes Jatenzo

Several categories of Florida clinicians regularly prescribe Jatenzo. Endocrinologists and urologists carry the highest volume because hypogonadism falls within their core scope. Men's health-focused primary care physicians and internal medicine physicians also prescribe TRT commonly [5].

Nurse practitioners (NPs) in Florida operate under a collaborative practice agreement with a supervising physician. Under that agreement, NPs may prescribe Schedule III controlled substances including testosterone [10]. Physician assistants (PAs) in Florida similarly require a supervisory relationship and a designated prescribing authority from their supervising physician to issue controlled substance prescriptions [10].

The Endocrine Society directory (endocrine.org/find-an-endocrinologist) and the American Urological Association's physician locator (auanet.org) both allow filtering by Florida zip code. For telehealth, platforms including HealthRX list their Florida-licensed prescriber roster on their state access pages.

When evaluating any Florida provider, ask three specific questions: Is the prescriber DEA-registered in Florida? Do they use a PDMP (Prescription Drug Monitoring Program) check at each visit, as required by Florida Statute 893.055? And do they have a follow-up protocol for the Jatenzo blood pressure warning at 6 weeks? A prescriber who cannot answer all three clearly is a red flag [11].

Prior Authorization in Florida: What Documents You Need

Most commercial insurers covering Jatenzo in Florida require prior authorization (PA). Florida Medicaid does not cover Jatenzo for male hypogonadism at all, so patients on Medicaid will pay out of pocket or pursue manufacturer assistance programs [12].

For commercial PA, the standard documentation packet includes: (1) two morning total testosterone results below 300 ng/dL drawn at least one week apart, (2) a diagnosis code of E29.1 (primary testicular failure) or E23.0 (hypogonadotropic hypogonadism), (3) documentation of at least one prior TRT trial and reason for transition (formulary step therapy often requires a topical or injectable trial first), and (4) the prescriber's clinical notes documenting symptoms including decreased libido, fatigue, loss of muscle mass, or depressed mood with measurable functional impairment [13].

The step-therapy requirement is common. Blue Cross Blue Shield of Florida, for instance, typically requires documentation that a topical testosterone gel (such as AndroGel 1.62%) was trialed for at least 90 days with either inadequate response or documented tolerability issue before approving an oral agent like Jatenzo [13]. A prescriber who anticipates this requirement can write the PA letter to include this documentation upfront, reducing back-and-forth by 5 to 10 business days.

PA decisions from Florida commercial insurers typically return within 3 to 5 business days. If denied, the prescriber may file an appeal with peer-to-peer review, which succeeds in approximately 40 to 60% of cases when clinical documentation is complete [14].

Jatenzo Pharmacy Fulfillment in Florida: Retail, Specialty, and 503A Options

Jatenzo is a brand-name drug manufactured by Tolmar and is not generically available. It is stocked at select retail and specialty pharmacies across Florida.

Major retail chains including CVS, Walgreens, and Publix pharmacies can order Jatenzo through their wholesaler (McKesson or AmerisourceBergen) if not immediately on shelf. Allow 24 to 72 hours for a special order at retail. Specialty pharmacies such as Optum Rx, Accredo, and Avita Pharmacy carry Jatenzo as a formulary item and ship to Florida addresses [15].

Regarding compounded testosterone undecanoate: 503A compounding pharmacies in Florida are licensed by the Florida Department of Health and the Florida Board of Pharmacy. They may compound testosterone undecanoate in oral form for individual patient prescriptions when a prescriber documents a clinical need that the commercially available product cannot meet (such as a specific dose not available in the 158 mg or 198 mg strengths). However, Florida's compounding regulations closely mirror USP Chapter 795 and 797 standards, and the Florida Board of Pharmacy conducts periodic inspections [16]. Compounded oral testosterone undecanoate is not FDA-approved and may carry different bioavailability characteristics than brand Jatenzo. Patients should discuss this distinction with their prescriber before accepting a compounded version as a cost-saving substitute.

The Tolmar manufacturer assistance program (patient-assistance@tolmar.com) provides Jatenzo at no cost to qualifying patients with household income below 400% of the federal poverty level and no adequate insurance coverage [17]. The application requires proof of income and a prescriber attestation.

Dosing, Titration, and Monitoring After the Prescription Is Filled

Starting Jatenzo at 158 mg twice daily with a fat-containing meal and titrating based on serum testosterone measured 4 to 6 hours after the morning dose is the FDA-labeled protocol [1]. The dose escalates to 198 mg twice daily if the 4-to-6-hour post-dose testosterone is below 400 ng/dL. If the level exceeds 1 to 050 ng/dL, the dose decreases back to 158 mg [1].

The fat requirement is not optional. A meal containing at least 20 grams of fat is needed for adequate lymphatic absorption. In the MAGE trial, taking Jatenzo with a low-fat or fasted state reduced AUC by approximately 40% compared to a fatty meal [2]. Patients who skip fat with their dose will have subtherapeutic testosterone levels and may incorrectly conclude the drug is not working.

Follow-up serum testosterone should be checked at 4 to 6 weeks, then every 6 months once stable [4]. CBC is checked at 3 to 6 months to monitor for erythrocytosis, which affects roughly 3 to 5% of men on any TRT [18]. Blood pressure must be measured at 6 weeks specifically per the FDA boxed warning, and documented in the medical record [1].

PSA is rechecked at 3 to 6 months in men over 40, then annually [5]. Any PSA rise exceeding 1.4 ng/mL over a 12-month period warrants urology referral before continuing TRT [5].

Transferring an Existing Jatenzo Prescription to Florida

Florida accepts transferred controlled substance prescriptions from other states under specific conditions. A Schedule III prescription, like Jatenzo, may be transferred once between DEA-registered pharmacies if the original prescription has remaining refills and has not expired [19]. The receiving Florida pharmacy must contact the originating out-of-state pharmacy directly to initiate the transfer.

Practically, this means a patient relocating to Florida can transfer one fill of an existing Jatenzo prescription to a Florida pharmacy. After that transfer, the prescription is exhausted and a Florida-licensed prescriber must issue a new prescription. Telehealth is an efficient route here: the patient books a video visit with a Florida-licensed provider, shares prior medical records documenting the hypogonadism diagnosis and prior TRT history, and the Florida prescriber can issue a new prescription after their own clinical evaluation [8].

Some telehealth platforms offer expedited transfers for patients already stabilized on TRT, reducing the intake process to a single video visit plus record review. Labs drawn within the prior 6 months may be acceptable without a repeat draw, at the prescriber's clinical judgment.

Cost Breakdown and Savings Programs for Florida Patients

Without insurance, Jatenzo's retail cash price in Florida ranges from approximately $540 to $620 per month for a 60-capsule supply (30-day course at twice-daily dosing). GoodRx coupons bring this to roughly $480 to $510 at major Florida chains depending on the pharmacy and zip code [20].

With commercial insurance and an approved PA, the copay ranges from $0 to $75 per month depending on formulary tier. Tolmar's copay assistance card reduces out-of-pocket costs to $0 for commercially insured patients for up to 12 months, with no income requirement. The card is available at jatenzo.com/savings [17].

Florida Medicare Part D plans vary significantly. In 2024, Jatenzo appeared on exactly 11 of 28 Florida Medicare Part D formularies, typically at Tier 4 or Tier 5 specialty status, with monthly patient costs ranging from $180 to $310 after deductible [21]. Medicare Part D enrollees should review their specific plan's formulary at Medicare.gov before assuming coverage.